Surfactant gene polymorphisms and interstitial lung diseases

Respiratory Research

Volumn 3, Issue , 2001, Pages

  Pantelidis, Panagiotis ^a   Veeraraghavan, Srihari ^a   du Bois, Roland M ^a  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

Genetics; Interstitial lung disease; Polymorphism; Surfactant

Indexed keywords

LUNG SURFACTANT; SURFACTANT PROTEIN A; SURFACTANT PROTEIN B; SURFACTANT PROTEIN C; SURFACTANT PROTEIN D;

ALLELE; ALLERGIC PNEUMONITIS; CHROMOSOME 6; DNA POLYMORPHISM; FIBROSING ALVEOLITIS; GENE EXPRESSION; GENE MUTATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC CODE; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; INTERSTITIAL LUNG DISEASE; LIPID ANALYSIS; LIPID COMPOSITION; LUNG ALVEOLUS PROTEINOSIS; LUNG LAVAGE; LUNG SARCOIDOSIS; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN ANALYSIS; PROTEIN CONTENT; REVIEW; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 25444468816     PISSN: 1465993X     EISSN: None     Source Type: Journal    
DOI: 10.1186/rr163     Document Type: Review

References (30)

1. Griese M: Pulmonary surfactant in health and human lung diseases: state of the art. Eur Respir J 1999, 13:1455-1476.
2. Low RB: Bronchoalveolar lavage lipids in idiopathic pulmonary fibrosis. Chest 1989, 95:3-5.
3. Gunther A, Schmidt R, Nix F, Yabut-Perez M, Guth C, Rosseau S, Siebert C, Grimminger F, Morr H, Velcovsky HG, Seeger W: Surfactant abnormalities in idiopathic pulmonary fibrosis, hypersensitivity pneumonitis and sarcoidosis. Eur Respir J 1999, 14:565-573.
4. McCormack FX, King TE, Jr., Bucher BL, Nielsen L, Mason RJ: Surfactant protein A predicts survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1995, 152:751-759.
5. van de Graaf EA, Jansen HM, Lutter R, Alberts C, Kobesen J, De Vries IJ, Out TA: Surfactant protein A in bronchoalveolar lavage fluid. J Lab Clin Med 1992, 120:252-263.
6. Hamm H, Luhrs J, Rotaeche J, Costabel U, Fabel H, Bartsch W: Elevated surfactant protein A in bronchoalveolar lavage fluids from sarcoidosis and hypersensitivity pneumonitis patients. Chest 1994, 106:1766-1770.
7. Cormier Y, Israel-Assayag E, Desmeules M, Lesur O: Effect of contact avoidance or treatment with oral prednisolone on bronchoalveolar lavage surfactant protein A levels in subjects with farmer's lung. Thorax 1996, 51:1210-1215.
8. Voss T, Schafer KP, Nielsen PF, Schafer A, Maier C, Hannappel E, Maassen J, Landis B, Klemm K, Przybylski M: Primary structure differences of human surfactant-associated proteins isolated from normal and proteinosis lung. Biochim Biophys Acta 1992, 1138:261-267.
9. Hattori A, Kuroki Y, Katoh T, Takahashi H, Shen HQ, Suzuki Y, Akino T: Surfactant protein A accumulating in the alveoli of patients with pulmonary alveolar proteinosis: oligomeric structure and interaction with lipids. Am J Respir Cell Mol Biol 1996, 14:608-619.
10. Takahashi H, Fujishima T, Koba H, Murakami S, Kurokawa K, Shibuya Y, Shiratori M, Kuroki Y, Abe S: Serum surfactant proteins A and D as prognostic factors in idiopathic pulmonary fibrosis and their relationship to disease extent. Am J Respir Crit Care Med 2000, 162:1109-1114.
11. Takahashi H, Kuroki Y, Tanaka H, Saito T, Kurokawa K, Chiba H, Sagawa A, Nagae H, Abe S: Serum levels of surfactant proteins A and D are useful biomarkers for interstitial lung disease in patients with progressive systemic sclerosis. Am J Respir Crit Care Med 2000, 162:258-263.
12. McGrath DS, Goh N, Foley PJ, du Bois RM: Sarcoidosis: genes and microbes-soil or seed? Sarcoidosis Vasc Diffuse Lung Dis 2001, 18:149-164.
13. Avila JJ, Lympany PA, Pantelidis P, Welsh KI, Black CM, du Bois RM: Fibronectin gene polymorphisms associated with fibrosing alveolitis in systemic sclerosis. Am J Respir Cell Mol Biol 1999, 20:106-112.
14. Gilchrist FC, Bunn C, Foley PJ, Lympany PA, Black CM, Welsh KI, du Bois RM: Class II HLA associations with autoantibodies in scleroderma: a highly significant role for HLA-DP. Genes Immun 2001, 2:76-81.
15. Pantelidis P, Fanning GC, Wells AU, Welsh KI, du Bois RM: Analysis of tumor necrosis factor-alpha, lymphotoxin-alpha, tumor necrosis factor receptor II, and interleukin-6 polymorphisms in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2001, 163:1432-1436.
16. Renzoni E, Lympany P, Sestini P, Pantelidis P, Wells A, Black C, Welsh K, Bunn C, Knight C, Foley P, du Bois RM: Distribution of novel polymorphisms of the interleukin-8 and CXC receptor 1 and 2 genes in systemic sclerosis and cryptogenic fibrosing alveolitis. Arthritis Rheum 2000, 43:1633-1640.
17. Whyte M, Hubbard R, Meliconi R, Whidborne M, Eaton V, Bingle C, Timms J, Duff G, Facchini A, Pacilli A, Fabbri M, Hall I, Britton J, Johnston I, Di Giovine F: Increased risk of fibrosing alveolitis associated with interleukin-1 receptor antagonist and tumor necrosis factor-alpha gene polymorphisms. Am J Respir Crit Care Med 2000, 162:755-758.
18. Karinch AM, deMello DE, Floros J: Effect of genotype on the levels of surfactant protein A mRNA and on the SP-A2 splice variants in adult humans. Biochem J 1997, 321 (Pt 1):39-47.
19. DiAngelo S, Lin Z, Wang G, Phillips S, Ramet M, Luo J, Floros J: Novel, non-radioactive, simple and multiplex PCR-cRFLP methods for genotyping human SP-A and SP-D marker alleles. Dis Markers 1999, 15:269-281.
20. Lin Z, deMello DE, Batanian JR, Khammash HM, DiAngelo S, Luo J, Floros J: Aberrant SP-B mRNA in lung tissue of patients with congenital alveolar proteinosis (CAP). Clin Genet 2000, 57: 359-369.
21. Floros J, Veletza SV, Kotikalapudi P, Krizkova L, Karinch AM, Friedman C, Buchter S, Marks K: Dinucleotide repeats in the human surfactant protein-B gene and respiratory-distress syndrome. Biochem J 1995, 305 (Pt 2):583-590.
22. Glasser SW, Korfhagen TR, Perme CM, Pilot-Matias TJ, Kister SE, Whitsett JA: Two SP-C genes encoding human pulmonary surfactant proteolipid. J Biol Chem 1988, 263:10326-10331.
23. Gelehrter TD, Collins FS: Population genetics and multifactorial inheritance. In: Principles of Medical Genetics, International Edition. Baltimore: Williams and Wilkins; 1990: 49-68.
24. Nogee LM, Wert SE, Proffit SA, Hull WM, Whitsett JA: Allelic heterogeneity in hereditary surfactant protein B (SP-B) deficiency. Am J Respir Crit Care Med 2000, 161:973-981.
25. Lin Z, deMello DE, Wallot M, Floros J: An SP-B gene mutation responsible for SP-B deficiency in fatal congenital alveolar proteinosis: evidence for a mutation hotspot in exon 4. Mol Genet Metab 1998, 64:25-35.
26. Nogee LM, Dunbar AE III, Wert SE, Askin F, Hamvas A, Whitsett JA: A mutation in the surfactant protein C gene associated with familial interstitial lung disease. N Engl J Med 2001, 344: 573-579.
27. Lin Z, Pearson C, Chinchilli V, Pietschmann SM, Luo J, Pison U, Floros J: Polymorphisms of human SP-A, SP-B, and SP-D genes: association of SP-B Thr131Ile with ARDS. Clin Genet 2000, 58:181-191.
28. Kala P, Ten Have T, Nielsen H, Dunn M, Floros J: Association of pulmonary surfactant protein A (SP-A) gene and respiratory distress syndrome: interaction with SP-B. Pediatr Res 1998, 43:169-177.
29. Haataja R, Ramet M, Marttila R, Hallman M: Surfactant proteins A and B as interactive genetic determinants of neonatal respiratory distress syndrome. Hum Mol Genet 2000, 9:2751-2760.
30. Weber B, Borkhardt A, Stoll-Becker S, Reiss I, Gortner L: Polymorphisms of surfactant protein A genes and the risk of bronchopulmonary dysplasia in preterm infants. Turk J Pediatr 2000, 42:181-185.